52 Week's Low
Returns % | |
1 Month Return | + 114.61 % |
3 Month Return | + 263.98 % |
1 Year Return | + 263.98 % |
Market Stats | |
Previous Close | ₹23.49 |
Open | ₹23.95 |
Volume | 1,742.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹12.31Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹12.31 Cr |
P/B Ratio | 0 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 1.15 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹12.31 Cr | 52.8% | -0.10 | NA | NA | |
NA | ₹10.17 Cr | 94.34% | 0.88 | NA | NA | |
NA | ₹261.26 Cr | 97.58% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹122.53 Cr | 40.58% | 0.51 | NA | NA | |
NA | ₹14,909.73 Cr | -1.26% | 0.73 | ₹82 Cr | ₹1,465 Cr |
Organisation | Venmax Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, Venmax Drugs stock has moved up by 129.0%
Best in 1 Year
In the last 1 year, Venmax Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 76.72% of holdings in Sep 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 23.14% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 76.72% | 0.00 | |
Others | 0.15% | 0.00 |
Venmax Drugs & Pharmaceuticals Ltd’s net profit fell -900% since last year same period to ₹0.30Cr in the Q2 2024-2025. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -3100% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Venmax Drugs & Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Venmax Drugs & Pharmaceuticals Ltd share price today stands at ₹23.95, Open. ₹23.95 ; Previous Close. ₹23.49 ; High. ₹23.95 ; Low. ₹23.95 ; 52 Week High. ₹23.95 ; 52 Week Low: ₹6.27.
Venmax Drugs & Pharmaceuticals Ltd is not listed on NSE
Venmax Drugs & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Venmax Drugs & Pharmaceuticals Ltd(531015) is 1,742.00.
Today’s market capitalisation of Venmax Drugs & Pharmaceuticals Ltd(531015) is ₹12.31Cr.
Venmax Drugs & Pharmaceuticals Ltd(531015 | Price |
---|---|
52 Week High | ₹23.95 |
52 Week Low | ₹6.27 |
Venmax Drugs & Pharmaceuticals Ltd(531015) share price is ₹23.95. It is down -0.00% from its 52 Week High price of ₹23.95
Venmax Drugs & Pharmaceuticals Ltd(531015) share price is ₹23.95. It is up 281.98% from its 52 Week Low price of ₹6.27
Venmax Drugs & Pharmaceuticals Ltd(531015 | Returns |
---|---|
1 Day Returns | 0.46% |
1 Month Returns | 114.61% |
3 Month Returns | 263.98% |
1 Year Returns | 263.98% |